(Q35012922)

5 August 2017

1 reference

title

Short-term and long-term modulation of gene expression by antisense therapeutics (English)

1 reference

5 August 2017

3

Ryszard Kole

1 reference

5 August 2017

Peter Sazani

1

1 reference

5 August 2017

Marla M Vacek

series ordinal

2

1 reference

5 August 2017

publication date

1 October 2002

1 reference

Current Opinion in Biotechnology

5 August 2017

published in

1 reference

5 August 2017

volume

13

1 reference

5 August 2017

issue

5

1 reference

5 August 2017

page(s)

468-472

1 reference

Heterocyclic modifications of oligonucleotides and antisense technology.

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2802%2900366-X

7 January 2021

Backbone modification of nucleic acids: synthesis, structure and therapeutic applications.

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2802%2900366-X

7 January 2021

Modification of alternative splicing by antisense oligonucleotides as a potential chemotherapy for cancer and other diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2802%2900366-X

7 January 2021

2'-carbohydrate modifications in antisense oligonucleotide therapy: importance of conformation, configuration and conjugation

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2802%2900366-X

7 January 2021

Importance of nucleotide sequence and chemical modifications of antisense oligonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2802%2900366-X

7 January 2021

2'-O,4'-C-Methylene bridged nucleic acid (2',4'-BNA): synthesis and triplex-forming properties

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2802%2900366-X

7 January 2021

2'-O,4'-C-methylene bridged nucleic acid modification promotes pyrimidine motif triplex DNA formation at physiological pH: thermodynamic and kinetic studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2802%2900366-X

7 January 2021

2'-O,4'-C-ethylene-bridged nucleic acids (ENA): highly nuclease-resistant and thermodynamically stable oligonucleotides for antisense drug

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2802%2900366-X

7 January 2021

Oligonucleotide N3'-->P5' phosphoramidates as potential therapeutic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2802%2900366-X

7 January 2021

Morpholino antisense oligomers: the case for an RNase H-independent structural type

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2802%2900366-X

7 January 2021

Crystal structure of double helical hexitol nucleic acids

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2802%2900366-X

7 January 2021

Restoration of hemoglobin A synthesis in erythroid cells from peripheral blood of thalassemic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2802%2900366-X

7 January 2021

Modification of alternative splicing of Bcl-x pre-mRNA in prostate and breast cancer cells. analysis of apoptosis and cell death.

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2802%2900366-X

7 January 2021

Correction of alternative splicing of tau in frontotemporal dementia and parkinsonism linked to chromosome 17.

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2802%2900366-X

7 January 2021

Modulation of survival motor neuron pre-mRNA splicing by inhibition of alternative 3' splice site pairing

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2802%2900366-X

7 January 2021

Nuclear antisense effects of neutral, anionic and cationic oligonucleotide analogs

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2802%2900366-X

7 January 2021

Phosphoramidate oligonucleotides as potent antisense molecules in cells and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2802%2900366-X

7 January 2021

Morpholino oligos: making sense of antisense?

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2802%2900366-X

7 January 2021

Gridlock signalling pathway fashions the first embryonic artery

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2802%2900366-X

7 January 2021

Inhibition of HIV-1 Tat-dependent trans activation by steric block chimeric 2'-O-methyl/LNA oligoribonucleotides.

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2802%2900366-X

7 January 2021

Restoration of correct splicing of thalassemic beta-globin pre-mRNA by modified U1 snRNAs

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2802%2900366-X

7 January 2021

Partial correction of endogenous DeltaF508 CFTR in human cystic fibrosis airway epithelia by spliceosome-mediated RNA trans-splicing

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2802%2900366-X

7 January 2021

In vivo targeting of SF/HGF and c-met expression via U1snRNA/ribozymes inhibits glioma growth and angiogenesis and promotes apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2802%2900366-X

7 January 2021

Effect of deletion and the site of insertion in double copy anti-tat retroviral vectors: viral titres and production of anti-tat mRNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2802%2900366-X

7 January 2021

Inhibition of HIV-1 replication by novel lentiviral vectors expressing transdominant Rev and HIV-1 env antisense

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2802%2900366-X

7 January 2021

Antisense Egr-1 RNA driven by the CMV promoter is an inhibitor of vascular smooth muscle cell proliferation and regrowth after injury

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2802%2900366-X

7 January 2021

In vivo control of NMDA receptor transcript level in motoneurons by viral transduction of a short antisense gene

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2802%2900366-X

7 January 2021

Regulation of human heme oxygenase in endothelial cells by using sense and antisense retroviral constructs

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2802%2900366-X

7 January 2021

Inhibition of carcinoma cell growth and metastasis by a vesicular stomatitis virus G-pseudotyped retrovector expressing type I insulin-like growth factor receptor antisense

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2802%2900366-X

7 January 2021

The future of hypertension therapy: sense, antisense, or nonsense?

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2802%2900366-X

7 January 2021

Blood pressure-independent attenuation of cardiac hypertrophy by AT(1)R-AS gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2802%2900366-X

7 January 2021

High-level expression of hemoglobin A in human thalassemic erythroid progenitor cells following lentiviral vector delivery of an antisense snRNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2802%2900366-X

7 January 2021

10.1016/S0958-1669(02)00366-X

Identifiers

DOI

1 reference

5 August 2017

1 reference